L&G Healthcare Breakthrough UCITS ETF (DOCT.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with DOCT.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to DOCT.L
DOCT.L charges 0.49% annually. There are 21 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 644.55M | Sep 2017 | DOCT.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 343.20M | Dec 2009 | DOCT.L vs XLVP.L | |
| Invesco Health Care S&P US Select Sector UCITS ETF... | 0.14% | 461.66M | Dec 2009 | DOCT.L vs XLVS.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.55B | Jun 2020 | DOCT.L vs IUHC.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 0.15% | — | Jul 2015 | DOCT.L vs GXLV.L |
Best Risk-Adjusted Alternatives to DOCT.L
DOCT.L has a PortfoliosLab risk / return rank of 40. There are 8 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 76.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 76 | 624.54M | Oct 2017 | DOCT.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 72 | 55.04M | Mar 2018 | DOCT.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 72 | 407.93M | Nov 2014 | DOCT.L vs SBIO.L | |
| Global X Genomics & Biotechnology UCITS ETF | 62 | 20.00M | Nov 2021 | DOCT.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 61 | 12.52M | Dec 2021 | DOCT.L vs WBIO.L |
Top Performing DOCT.L Alternatives (YTD)
DOCT.L is at 0.41% YTD. There are 9 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.27%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 12.27% | 20.00M | Nov 2021 | DOCT.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 12.52M | Dec 2021 | DOCT.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.97% | 9.55M | May 2020 | DOCT.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 624.54M | Oct 2017 | DOCT.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 4.58% | 55.04M | Mar 2018 | DOCT.L vs BTEE.L |
Lowest Volatility Alternatives to DOCT.L
DOCT.L has 21.03% 1-year volatility. There are 24 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.70%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.70% | — | Apr 2016 | DOCT.L vs HEAW.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | 14.52% | 913.84M | Aug 2010 | DOCT.L vs HLTW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.57% | 3.40B | Mar 2016 | DOCT.L vs XDWH.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 14.72% | 644.55M | Sep 2017 | DOCT.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 14.76% | 343.20M | Dec 2009 | DOCT.L vs XLVP.L |
Lowest Drawdown Alternatives to DOCT.L
DOCT.L has a 1-year max drawdown of -17.02%. There are 24 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 624.54M | Oct 2017 | DOCT.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.63% | 55.04M | Mar 2018 | DOCT.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.64% | 407.93M | Nov 2014 | DOCT.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.12M | Jan 2018 | DOCT.L vs BIGT.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | -10.12% | 913.84M | Aug 2010 | DOCT.L vs HLTW.L |
Other ETFs from Legal & General
The 10 most viewed Legal & General ETFs shown here include LGGG.L, AIAI.L, AIAG.L and span 7 categories. AUM among these funds goes as high as $2B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| L&G Global Equity UCITS ETF | Global Equities | 82 | 10.12% | 968.63M | Nov 2018 | DOCT.L vs LGGG.L | |
| L&G Artificial Intelligence UCITS ETF | Technology Equities | 83 | 42.35% | 1.72B | Jun 2019 | DOCT.L vs AIAI.L | |
| L&G Artificial Intelligence UCITS ETF | Technology Equities | 82 | 41.86% | 1.28B | Jun 2019 | DOCT.L vs AIAG.L | |
| L&G Gold Mining UCITS ETF | Precious Metals | 41 | -0.57% | 630.36M | Nov 2008 | DOCT.L vs AUCP.L | |
| L&G Quality Equity Dividends ESG Exclusions Europe... | Europe Equities | 78 | 10.41% | 405.45M | Apr 2021 | DOCT.L vs LDEG.L | |
| L&G All Commodities UCITS ETF | Commodities | 64 | 24.98% | 318.12M | Jul 2017 | DOCT.L vs BCOG.L | |
| L&G ROBO Global Robotics and Automation UCITS ETF | Robotics, Technology Equities | 82 | 28.02% | 1.02B | Oct 2014 | DOCT.L vs ROBG.L | |
| L&G Quality Equity Dividends ESG Exclusions UK UCI... | Europe Equities | 26 | 3.01% | 68.80M | Apr 2021 | DOCT.L vs LDUK.L | |
| L&G Clean Water UCITS ETF | Water Equities | 21 | 2.12% | 500.12M | Jun 2019 | DOCT.L vs GLGG.L | |
| L&G UK Equity UCITS ETF | Europe Equities | 38 | 3.73% | 171.52M | Nov 2018 | DOCT.L vs LGUK.L |
Often Compared With DOCT.L
Investors most often compare DOCT.L with IUIT.L, HTEC, WHCE.L. These 10 comparison targets span 5 categories, based on PortfoliosLab usage data.
Compare DOCT.L with Any Fund or Stock
Compare DOCT.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair DOCT.L with funds that move differently
L&G Healthcare Breakthrough UCITS ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to DOCT.L.
Explore DOCT.L Diversifiers